Signalling, trafficking and glucoregulatory properties of glucagon-like peptide-1 receptor agonists exendin-4 and lixisenatide. (2020)
Attributed to:
Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bph.15134
PubMed Identifier: 32436216
Publication URI: http://europepmc.org/abstract/MED/32436216
Type: Journal Article/Review
Volume: 177
Parent Publication: British journal of pharmacology
Issue: 17
ISSN: 0007-1188